Stephen Haworth
Technik-/Wissenschafts-/F&E-Leiter bei XORTX THERAPEUTICS INC.
Vermögen: - $ am 30.04.2024
Aktive Positionen von Stephen Haworth
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| XORTX THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2021 | - |
Karriereverlauf von Stephen Haworth
Ehemalige bekannte Positionen von Stephen Haworth
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CORMEDIX INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2017 | 01.01.2018 |
Elusys Therapeutics, Inc.
 Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2012 | 01.04.2013 |
VaxInnate Corp.
 VaxInnate Corp. Pharmaceuticals: MajorHealth Technology VaxInnate Corp. develops novel, proprietary vaccines for infectious diseases. It engages in the development and production of vaccines for pandemic and seasonal influenza diseases. The firm's products include Flagellin.HuHA and flagellin.AvHA, which are fusion proteins linking a potent immune stimulator, the bacterial protein flagellin, with immunoprotective domain of viral hemagglutinin. The company was founded by Ruslan Medzhitov, Michael I. Sherman and Richard Flavell in 2002 and is headquartered in Cranbury, NJ. | Corporate Officer/Principal | 01.04.2015 | 01.04.2016 |
Ausbildung von Stephen Haworth
| UCL Medical School | Doctorate Degree |
| University College London | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| Vereinigtes Königreich | 3 |
| Kanada | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| XORTX THERAPEUTICS INC. | Health Technology |
| CORMEDIX INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Elusys Therapeutics, Inc.
Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | Health Technology |
VaxInnate Corp.
VaxInnate Corp. Pharmaceuticals: MajorHealth Technology VaxInnate Corp. develops novel, proprietary vaccines for infectious diseases. It engages in the development and production of vaccines for pandemic and seasonal influenza diseases. The firm's products include Flagellin.HuHA and flagellin.AvHA, which are fusion proteins linking a potent immune stimulator, the bacterial protein flagellin, with immunoprotective domain of viral hemagglutinin. The company was founded by Ruslan Medzhitov, Michael I. Sherman and Richard Flavell in 2002 and is headquartered in Cranbury, NJ. | Health Technology |
- Börse
- Insiders
- Stephen Haworth
- Erfahrung